home / stock / gthx / gthx articles

GTHX Articles, G1 Therapeutics Inc. - From 01/03/24

Stock Information
Company Name: G1 Therapeutics Inc.
Stock Symbol: GTHX
Market: NASDAQ
Website: g1therapeutics.com
Menu
GTHX GTHX Quote GTHX Short GTHX News GTHX Articles GTHX Message Board
Get GTHX Alerts

News, Short Squeeze, Breakout and More Instantly...
G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today ...
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Benzinga

RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today ...

G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium | Benzinga

RESEARCH TRIANGLE PARK, N.C., Nov. 29, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today ...

Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Gainers Cellectis S.A. (NASDAQ: CLLS) shares jumped 136% to $2.2799. Cellectis reported strategic collaboration and investment agreements with As...
Real World Data Indicate That Trilaciclib Reduces Hospitalizations and Myelosuppressive Events and May Improve Survival in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) | Benzinga

RESEARCH TRIANGLE PARK, N.C., Oct. 27, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today ...

Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Gainers SeaStar Medical Holding Corporation (NASDAQ: ICU) shares climbed 36.4% to $1.0516. SeaStar medical shares jumped 70% on Wednesday after t...

G1 Therapeutics Announces Upcoming Presentations at the 2023 ASCO Quality Care Symposium | Benzinga

RESEARCH TRIANGLE PARK, N.C., Oct. 16, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today ...
Black Diamond Therapeutics Announces CEO Transition | Benzinga

Current Chairman of the Board and industry veteran Mark Velleca appointed CEO CAMBRIDGE, Mass. and NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- ...

G1 Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference | Benzinga

RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today...

Previous 10 Next 10